233 related articles for article (PubMed ID: 23589336)
1. Defining the role of high-dose statins in PCI.
Guarini G; Marzilli M
Am J Cardiovasc Drugs; 2013 Jun; 13(3):189-97. PubMed ID: 23589336
[TBL] [Abstract][Full Text] [Related]
2. Statins in acute coronary syndrome: very early initiation and benefits.
Angeli F; Reboldi G; Mazzotta G; Garofoli M; Cerasa MF; Verdecchia P
Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):163-74. PubMed ID: 22789992
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
4. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
5. Statin withdrawal: clinical implications and molecular mechanisms.
Cubeddu LX; Seamon MJ
Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
[TBL] [Abstract][Full Text] [Related]
6. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.
Tentzeris I; Rohla M; Jarai R; Farhan S; Freynhofer MK; Unger G; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K
Am J Cardiol; 2014 Apr; 113(7):1099-104. PubMed ID: 24462073
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects and cholesterol-lowering therapy.
Shaw SM; Fildes JE; Yonan N; Williams SG
Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
[TBL] [Abstract][Full Text] [Related]
8. Preprocedural statin therapy in percutaneous coronary intervention.
Cahoon WD; Crouch MA
Ann Pharmacother; 2007 Oct; 41(10):1687-93. PubMed ID: 17712042
[TBL] [Abstract][Full Text] [Related]
9. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
11. Utility of early high dose statins in acute coronary syndrome.
Dougherty PJ; Arora RR
Am J Ther; 2012 Sep; 19(5):369-76. PubMed ID: 22964560
[TBL] [Abstract][Full Text] [Related]
12. Update on the efficacy of statin treatment in acute coronary syndromes.
Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
[TBL] [Abstract][Full Text] [Related]
13. Current questions regarding the use of statins in patients with coronary heart disease.
Rallidis LS; Lekakis J; Kremastinos DT
Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827
[TBL] [Abstract][Full Text] [Related]
14. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms.
Merla R; Daher IN; Ye Y; Uretsky BF; Birnbaum Y
Am Heart J; 2007 Aug; 154(2):391-402. PubMed ID: 17643594
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
18. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
19. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of complications after percutaneous coronary interventions with statins].
Mega S; Nusca A; Patti G
Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
